Cellectis Inc., and Oncology firm, is in serious talk with Pfizer to get its Euro 1.5 billion stake of the firm.
Pfizer has already owns 9.5% of the company.
View the full release here.
Cellectis Inc., and Oncology firm, is in serious talk with Pfizer to get its Euro 1.5 billion stake of the firm.
Pfizer has already owns 9.5% of the company.
View the full release here.